ArticleScientific reports2026
Whole transcriptome sequencing and ceRNA regulatory network in diabetic peripheral neuropathy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although diabetic peripheral neuropathy (DPN) is a serious complication of diabetes, its molecular causes are still unclear. The aim of this study was therefore to further investigate the pathogenesis of diabetes through whole transcriptome sequencing.
methodsWe performed whole transcriptome sequencing on sciatic nerve samples from Sprague-Dawley (SD) rats. Based on the whole transcriptome sequencing data, the differentially expressed genes (DEGs) between the DPN and the control groups were identified, and functions and pathways in which DEGs were enriched were analyzed. Thereafter, the protein-protein interaction (PPI) network was built, and the top 20 hub genes were screened via STRING algorithm. In addition, enrichment analysis for the top 20 hub genes was subsequently performed. Finally, the competing endogenous RNA (ceRNA) network was created.
resultsThere were 597 DEGs between the DPN group and the control groups. The top 20 hub genes were Fos, Tnf, Jun, Cd3e, Cd79a, Cd27, Cd79b, Ptprc, Cd22, Cd40lg, Cd19, Cr2, Sell, Il6, Pdlim3, Actn2, Myom2, Tnni2, Ldb3, and Myh7. According to the enrichment analysis, DEGs and hub genes were enriched into the following: 'B cell receptor signaling pathway', 'TNF signaling pathway', 'T cell receptor signaling pathway' 'Th17 cell differentiation', 'IL-17 signaling pathway', 'primary immunodeficiency', and 'toll-like receptor signaling pathway'. The ceRNA network finally contained 9 mRNAs, 23 miRNAs, and 23 lncRNAs.
conclusionsThis study was able to determine that hub genes such as Fos and Jun may be involved in the progression of DPN by regulating signaling pathways like the B cell receptor signaling pathway, the TNF signaling pathway, and the IL-17 signaling pathway. The findings of this study could provide novel insights into the roles of DEGs in the pathogenesis of DPN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.